Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sandra J. Lewis, Temitope Olufade, Deborah A. Anzalone, Elisabetta Malangone-Monaco, Kristin A. Evans & Stephen Johnston. (2018) LDL cholesterol levels after switch from atorvastatin to rosuvastatin. Current Medical Research and Opinion 34:10, pages 1717-1723.
Read now
Read now
Christos V. Rizos & Moses S. Elisaf. (2016) Telmisartan: a multifaceted antihypertension drug. Current Medical Research and Opinion 32:8, pages 1397-1398.
Read now
Read now
Anastazia A. Kei, Theodosios D. Filippatos & Moses S. Elisaf. (2016) The safety of ezetimibe and simvastatin combination for the treatment of hypercholesterolemia. Expert Opinion on Drug Safety 15:4, pages 559-569.
Read now
Read now
Articles from other publishers (7)
Jean Ferrières, Eric Bruckert, Michel Farnier, Michel Krempf, Jean-Jacques Mourad, Baptiste Roux & François Schiele. (2023) Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study. Journal of Comparative Effectiveness Research.
Crossref
Crossref
Christos V. Rizos, Matilda Florentin, Ioannis Skoumas, Konstantinos Tziomalos, Loukianos Rallidis, Vasileios Kotsis, Vasileios Athyros, Emmanouil Skalidis, Genovefa Kolovou, Anastasia Garoufi, Eleni Bilianou, Iosif Koutagiar, Dimitrios Agapakis, Estela Kiouri, Christina Antza, Niki Katsiki, Evangelos Zacharis, Achilleas Attilakos, George Sfikas, Panagiotis Anagnostis, Demosthenes B. Panagiotakos & Evangelos N. Liberopoulos. (2020) Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry. Lipids in Health and Disease 19:1.
Crossref
Crossref
O.S. Lunegova, A.E. Mirrakhimov, E. Hodzhiboboev, E.E. Bektasheva, K.V. Neronova, U.M. Toktomamatov, U. Zakirov, A. Asanbaev, R.A. Arapova, S.S. Abilova, A.S. Kerimkulova & E.M. Mirrakhimov. (2019) The frequency of familial hypercholesterolemia amongst patients in the outpatient clinic of the tertiary specialized cardiology center in Kyrgyzstan. Atherosclerosis Supplements 36, pages 1-5.
Crossref
Crossref
Woohyeun Kim, Yeonyee E. Yoon, Sung-Hee Shin, Jang-Whan Bae, Bum-Kee Hong, Soon Jun Hong, Ki Chul Sung, Seung Hwan Han, Weon Kim, Moo-Yong Rhee, Sang-Hyun Kim, Sang Eun Lee, Min Su Hyon, Gyo-Seung Hwang, Jang Won Son, Jang-Young Kim, Min Kyu Kim, Sang Wook Kim, Jae-Hyeong Park, Jin Ho Shin & Chang Gyu Park. (2018) Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia. Clinical Therapeutics 40:6, pages 993-1013.
Crossref
Crossref
Christoph Waldeyer, Moritz Seiffert, Nils Staebe, Julian Braetz, Rebecca Kohsiack, Francisco Ojeda, Niklas Schofer, Mahir Karakas, Tanja Zeller, Christoph Sinning, Benedikt Schrage, Dirk Westermann, Karsten Sydow, Stefan Blankenberg, Fabian J. Brunner & Renate B. Schnabel. (2017) Lipid Management After First Diagnosis of Coronary Artery Disease: Contemporary Results From an Observational Cohort Study. Clinical Therapeutics 39:11, pages 2311-2320.e2.
Crossref
Crossref
Christos V. Rizos, Vasilios Athyros, Eleni Bilianou, George Chrousos, Anastasia Garoufi, Genovefa Kolovou, Vasilios Kotsis, Loukianos Rallidis, Emmanouel Skalidis, Ioannis Skoumas, Konstantinos Tziomalos & Evangelos N. Liberopoulos. (2017) An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH). Hormones 16:3, pages 306-312.
Crossref
Crossref
Elahe Yousefi, Saeid Zareiy, Rosa Zavoshy, Mostafa Noroozi, Hassan Jahanihashemi & Hamidreza Ardalani. (2017) Fenugreek: A therapeutic complement for patients with borderline hyperlipidemia: A randomised, double-blind, placebo-controlled, clinical trial. Advances in Integrative Medicine 4:1, pages 31-35.
Crossref
Crossref